NVDA
NVIDIA
-- 121.670 TSLA
Tesla
-- 249.980 QBTS
D-Wave Quantum
-- 10.150 PLTR
Palantir
-- 86.240 INTC
Intel
-- 24.050 
Looks right
$ChemoCentryx (CCXI.US)$
CHMP opinion was 11-12-21.
EU marketing approval due before 1-18-22
Strong Buy recommendation on the stock. Raymond James has a Street high target of $110 per share for ChemoCentryx (CCXI) to imply a premium of ~240.0% to the last close.
Also coming off a triple bottom bounce.
CHMP opinion was 11-12-21.
EU marketing approval due before 1-18-22
Strong Buy recommendation on the stock. Raymond James has a Street high target of $110 per share for ChemoCentryx (CCXI) to imply a premium of ~240.0% to the last close.
Also coming off a triple bottom bounce.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Mcsnacks H Tupack OP : Tomorrow will be the last day to get in before announcement. A lot of shorts haven’t covered like last time. Last time it doubled the price.
babyya : @Jzng@Jeanstarxin
silverelf : Moving from CNTX back to CCXI?
风光3265 silverelf : That's what I thought.
Day Trader 881 : Super strong support at 32.. but do remember what they did to us the day before FDA during AH….. stop loss hunted , which is manipulation at its best..
not setting stop loss this time round.
Good luck everyone
Invest and learn : Extracted text from website (https://www.ema.europa.eu/en/about-us/what-we-do/authorisation-medicines)
Cat army silverelf : Nope from CNTX.US to PETZ.US to CCXI.US
Mcsnacks H Tupack OP silverelf : This will be one of the few stocks that will finish in the green today. 3 day weekends are brutal for the market
babyya Mcsnacks H Tupack OP : When will think the ccxi will appoval date?
Bernard With Bacon babyya : Next Monday
View more comments...